NCT02182856View on ClinicalTrials.gov

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

July 31, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ipratropium bromide 500 µg/salbutamol sulphate 3 mg

DRUG

Ipratropium 500 µg

DRUG

Salbutamol sulphate 3 mg

DRUG

Salbutamol sulphate 6 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY